The effect of selective antagonist of the arginine vasopressin (AVP) V1b receptors on the secretion of ACTH and corticosteroids in response to insulin-induced hypoglycemia and injection of AVP is studied in old Macaca mulatta females with depression-like and anxious behavior. Intravenous antagonist in a dose of 1.1-1.7 μg/kg inhibits the increase of ACTH concentration, induced by hypoglycemia or injection of AVP. The degree of increase in the concentrations of hydrocortisone and dehydroepiandrosterone sulfate has not changed or increased. The effects of AVP antagonist prove that previously detected disorders in the reaction of the hypothalamic—pituitary—adrenal system in old Macaca mulatta with depression-like and anxious behavior could be caused by excessive activation of vasopressin V1b receptors on the pituitary corticotrophs, while the use of V1b receptor antagonists seems to be a promising method for prevention of these disorders.
Similar content being viewed by others
References
Vygotskii MYu. Handbook of Higher Mathematics. Moscow, 1962. Russian.
Jasnic N, Djordjevic J, Vujovic P, Lakic I, Djurasevic S, Cvijic G. The effect of vasopressin 1b receptor (V1bR) blockade on HPA axis activity in rats exposed to acute heat stress. J. Exp. Biol. 2013;216(Pt 12):2302-2307.
Goncharova ND, Marenin VY, Oganyan TE. Aging of the hypothalamic—pituitary—adrenal axis in nonhuman primates with depression-like and aggressive behavior. mAging (Albany NY). 2010;2(11):854-866.
Goncharova ND, Marenin VYu, Oganyan TE. Individual differences in stress responsiveness of the hypothalamic—pituitary—adrenal axis and its vasopressinergic regulation in old monkeys. J. Behav. Brain Sci. 2015;5(7):280-294. doi: https://doi.org/10.4236/jbbs.2015.57029.
Goncharova ND, Oganyan TE. Age-related differences in stress responsiveness of the hypothalamic—pituitary—adrenal axis of nonhuman primates with various types of adaptive behavior. Gen. Comp. Endocrinol. 2018;258:163-172.
Goncharova ND, Oganyan TE, Marenin VY, Vengerin AA. Age-specific and individual features of vasopressinergic regulation of the hypothalamic—pituitary—adrenal system in primates. Bull. Exp. Biol. Med. 2015;158(6):804-806.
Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, Durroux T, Mouillac B, Corbani M, Guillon G. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J. Neuroendocrinol. 2012;24(4):609-628.
Roper JA, O’Carroll AM, Young WS, Lolait SJ. The vasopressin Avprlb receptor: Molecular and pharmacological studies. Stress. 2011;14(1):98-115.
Serradeil-Le Gal C, Derick S, Brossard G, Manning M, Simiand J, Gaillard R, Griebel G, Guillon G. Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals. Stress. 2003;6(3):199-206.
Spiga F, Harrison LR, Wood S, Knight DM, MacSweeney CP, Thomson F, Craighead M, Lightman SL. Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic—pituitary—adrenal axis activity. J. Endocrinol. 2009;200(3):273-283.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 7, pp. 96-102, July, 2018
Rights and permissions
About this article
Cite this article
Goncharova, N.D., Chigarova, O.A. & Oganyan, T.E. Effect of Vasopressin V1b Receptor Blockade on Activity of the Hypothalamic—Pituitary—Adrenal Axis in Old Monkeys with Depression-Like and Anxious Behavior Subjected to Stress or Injected with Vasopressin. Bull Exp Biol Med 166, 86–91 (2018). https://doi.org/10.1007/s10517-018-4294-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4294-4